1 Market Overview of Gene Therapy For Heart Failure 1.1 Gene Therapy For Heart Failure Market Overview 1.1.1 Gene Therapy For Heart Failure Product Scope 1.1.2 Gene Therapy For Heart Failure Market Status and Outlook 1.2 Global Gene Therapy For Heart Failure Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Gene Therapy For Heart Failure Market Size by Region (2016-2027) 1.4 Global Gene Therapy For Heart Failure Historic Market Size by Region (2016-2021) 1.5 Global Gene Therapy For Heart Failure Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Gene Therapy For Heart Failure Market Size (2016-2027) 1.6.1 North America Gene Therapy For Heart Failure Market Size (2016-2027) 1.6.2 Europe Gene Therapy For Heart Failure Market Size (2016-2027) 1.6.3 Asia-Pacific Gene Therapy For Heart Failure Market Size (2016-2027) 1.6.4 Latin America Gene Therapy For Heart Failure Market Size (2016-2027) 1.6.5 Middle East & Africa Gene Therapy For Heart Failure Market Size (2016-2027) 2 Gene Therapy For Heart Failure Market Overview by Type 2.1 Global Gene Therapy For Heart Failure Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Gene Therapy For Heart Failure Historic Market Size by Type (2016-2021) 2.3 Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2022-2027) 2.4 Gene Modification 2.5 Gene Replacement 2.6 Others 3 Gene Therapy For Heart Failure Market Overview by Application 3.1 Global Gene Therapy For Heart Failure Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Gene Therapy For Heart Failure Historic Market Size by Application (2016-2021) 3.3 Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Laboratory 3.6 Others 4 Gene Therapy For Heart Failure Competition Analysis by Players 4.1 Global Gene Therapy For Heart Failure Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2020) 4.3 Date of Key Players Enter into Gene Therapy For Heart Failure Market 4.4 Global Top Players Gene Therapy For Heart Failure Headquarters and Area Served 4.5 Key Players Gene Therapy For Heart Failure Product Solution and Service 4.6 Competitive Status 4.6.1 Gene Therapy For Heart Failure Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Askbio 5.1.1 Askbio Profile 5.1.2 Askbio Main Business 5.1.3 Askbio Gene Therapy For Heart Failure Products, Services and Solutions 5.1.4 Askbio Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.1.5 Askbio Recent Developments 5.2 RENOVACORINC 5.2.1 RENOVACORINC Profile 5.2.2 RENOVACORINC Main Business 5.2.3 RENOVACORINC Gene Therapy For Heart Failure Products, Services and Solutions 5.2.4 RENOVACORINC Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.2.5 RENOVACORINC Recent Developments 5.3 Uniqure 5.5.1 Uniqure Profile 5.3.2 Uniqure Main Business 5.3.3 Uniqure Gene Therapy For Heart Failure Products, Services and Solutions 5.3.4 Uniqure Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.3.5 DINAQOR Recent Developments 5.4 DINAQOR 5.4.1 DINAQOR Profile 5.4.2 DINAQOR Main Business 5.4.3 DINAQOR Gene Therapy For Heart Failure Products, Services and Solutions 5.4.4 DINAQOR Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.4.5 DINAQOR Recent Developments 5.5 PRECIGEN 5.5.1 PRECIGEN Profile 5.5.2 PRECIGEN Main Business 5.5.3 PRECIGEN Gene Therapy For Heart Failure Products, Services and Solutions 5.5.4 PRECIGEN Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.5.5 PRECIGEN Recent Developments 5.6 Heartseed 5.6.1 Heartseed Profile 5.6.2 Heartseed Main Business 5.6.3 Heartseed Gene Therapy For Heart Failure Products, Services and Solutions 5.6.4 Heartseed Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.6.5 Heartseed Recent Developments 5.7 Cardior 5.7.1 Cardior Profile 5.7.2 Cardior Main Business 5.7.3 Cardior Gene Therapy For Heart Failure Products, Services and Solutions 5.7.4 Cardior Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.7.5 Cardior Recent Developments 5.8 NOVARTIS 5.8.1 NOVARTIS Profile 5.8.2 NOVARTIS Main Business 5.8.3 NOVARTIS Gene Therapy For Heart Failure Products, Services and Solutions 5.8.4 NOVARTIS Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.8.5 NOVARTIS Recent Developments 5.9 Blue Rock 5.9.1 Blue Rock Profile 5.9.2 Blue Rock Main Business 5.9.3 Blue Rock Gene Therapy For Heart Failure Products, Services and Solutions 5.9.4 Blue Rock Gene Therapy For Heart Failure Revenue (US$ Million) & (2016-2021) 5.9.5 Blue Rock Recent Developments 6 North America 6.1 North America Gene Therapy For Heart Failure Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Gene Therapy For Heart Failure Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Gene Therapy For Heart Failure Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Gene Therapy For Heart Failure Market Dynamics 11.1 Gene Therapy For Heart Failure Industry Trends 11.2 Gene Therapy For Heart Failure Market Drivers 11.3 Gene Therapy For Heart Failure Market Challenges 11.4 Gene Therapy For Heart Failure Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Gene Therapy For Heart Failure Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Gene Therapy For Heart Failure Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Gene Therapy For Heart Failure Market Size Share by Region (2016-2021) Table 4. Global Gene Therapy For Heart Failure Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Gene Therapy For Heart Failure Forecasted Market Size Share by Region (2022-2027) Table 6. Global Gene Therapy For Heart Failure Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Gene Therapy For Heart Failure Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2016-2021) Table 9. Global Gene Therapy For Heart Failure Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Gene Therapy For Heart Failure Revenue Market Share by Type (2022-2027) Table 11. Global Gene Therapy For Heart Failure Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Gene Therapy For Heart Failure Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2016-2021) Table 14. Global Gene Therapy For Heart Failure Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Gene Therapy For Heart Failure Revenue Market Share by Application (2022-2027) Table 16. Global Gene Therapy For Heart Failure Revenue (US$ Million) by Players (2016-2021) Table 17. Global Gene Therapy For Heart Failure Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gene Therapy For Heart Failure as of 2020) Table 19. Date of Key Manufacturers Enter into Gene Therapy For Heart Failure Market Table 20. Global Gene Therapy For Heart Failure Top Players Headquarters and Area Served Table 21. Gene Therapy For Heart Failure Product Solution and Service Table 22. Global Gene Therapy For Heart Failure Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Askbio Basic Information List Table 25. Askbio Description and Business Overview Table 26. Askbio Gene Therapy For Heart Failure Products, Services and Solutions Table 27. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of Askbio (2016-2021) Table 28. Askbio Recent Developments Table 29. RENOVACORINC Basic Information List Table 30. RENOVACORINC Description and Business Overview Table 31. RENOVACORINC Gene Therapy For Heart Failure Products, Services and Solutions Table 32. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of RENOVACORINC (2016-2021) Table 33. RENOVACORINC Recent Developments Table 34. Uniqure Basic Information List Table 35. Uniqure Description and Business Overview Table 36. Uniqure Gene Therapy For Heart Failure Products, Services and Solutions Table 37. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of Uniqure (2016-2021) Table 38. Uniqure Recent Developments Table 39. DINAQOR Basic Information List Table 40. DINAQOR Description and Business Overview Table 41. DINAQOR Gene Therapy For Heart Failure Products, Services and Solutions Table 42. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of DINAQOR (2016-2021) Table 43. DINAQOR Recent Developments Table 44. PRECIGEN Basic Information List Table 45. PRECIGEN Description and Business Overview Table 46. PRECIGEN Gene Therapy For Heart Failure Products, Services and Solutions Table 47. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of PRECIGEN (2016-2021) Table 48. PRECIGEN Recent Developments Table 49. Heartseed Basic Information List Table 50. Heartseed Description and Business Overview Table 51. Heartseed Gene Therapy For Heart Failure Products, Services and Solutions Table 52. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of Heartseed (2016-2021) Table 53. Heartseed Recent Developments Table 54. Cardior Basic Information List Table 55. Cardior Description and Business Overview Table 56. Cardior Gene Therapy For Heart Failure Products, Services and Solutions Table 57. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of Cardior (2016-2021) Table 58. Cardior Recent Developments Table 59. NOVARTIS Basic Information List Table 60. NOVARTIS Description and Business Overview Table 61. NOVARTIS Gene Therapy For Heart Failure Products, Services and Solutions Table 62. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of NOVARTIS (2016-2021) Table 63. NOVARTIS Recent Developments Table 64. Blue Rock Basic Information List Table 65. Blue Rock Description and Business Overview Table 66. Blue Rock Gene Therapy For Heart Failure Products, Services and Solutions Table 67. Revenue (US$ Million) in Gene Therapy For Heart Failure Business of Blue Rock (2016-2021) Table 68. Blue Rock Recent Developments Table 69. North America Gene Therapy For Heart Failure Market Size by Country (2016-2021) & (US$ Million) Table 70. North America Gene Therapy For Heart Failure Market Size by Country (2022-2027) & (US$ Million) Table 71. Europe Gene Therapy For Heart Failure Market Size by Country (2016-2021) & (US$ Million) Table 72. Europe Gene Therapy For Heart Failure Market Size by Country (2022-2027) & (US$ Million) Table 73. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2016-2021) & (US$ Million) Table 74. Asia-Pacific Gene Therapy For Heart Failure Market Size by Region (2022-2027) & (US$ Million) Table 75. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2016-2021) Table 76. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2022-2027) Table 77. Latin America Gene Therapy For Heart Failure Market Size by Country (2016-2021) & (US$ Million) Table 78. Latin America Gene Therapy For Heart Failure Market Size by Country (2022-2027) & (US$ Million) Table 79. Middle East & Africa Gene Therapy For Heart Failure Market Size by Players (2016-2021) & (US$ Million) Table 80. Middle East & Africa Gene Therapy For Heart Failure Market Size by Country (2022-2027) & (US$ Million) Table 81. Gene Therapy For Heart Failure Market Trends Table 82. Gene Therapy For Heart Failure Market Drivers Table 83. Gene Therapy For Heart Failure Market Challenges Table 84. Gene Therapy For Heart Failure Market Restraints Table 85. Research Programs/Design for This Report Table 86. Key Data Information from Secondary Sources Table 87. Key Data Information from Primary Sources List of Figures Figure 1. Global Gene Therapy For Heart Failure Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Gene Therapy For Heart Failure Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Gene Therapy For Heart Failure Market Share by Regions: 2021 VS 2027 Figure 4. Global Gene Therapy For Heart Failure Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Gene Therapy For Heart Failure Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Gene Therapy For Heart Failure Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Gene Therapy For Heart Failure Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Gene Therapy For Heart Failure Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Gene Therapy For Heart Failure Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Gene Therapy For Heart Failure Market Size Share by Type in 2021 & 2027 Figure 11. Gene Modification Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Gene Replacement Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Global Gene Therapy For Heart Failure Market Size Share by Application in 2021 & 2027 Figure 15. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Laboratory Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Gene Therapy For Heart Failure Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 19. Global Top 5 and Top 10 Players Gene Therapy For Heart Failure Market Share in 2020 Figure 20. North America Gene Therapy For Heart Failure Market Share by Country (2016-2027) Figure 21. United States Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 22. Canada Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 23. Germany Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 24. France Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 25. U.K. Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 26. Italy Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 27. Russia Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 28. Nordic Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 29. Rest of Europe Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 30. Asia-Pacific Gene Therapy For Heart Failure Market Share by Region (2016-2027) Figure 31. China Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 32. Japan Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 33. South Korea Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 34. Southeast Asia Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 35. India Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 36. Australia Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 37. Rest of Asia-Pacific Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 38. Latin America Gene Therapy For Heart Failure Market Share by Country (2016-2027) Figure 39. Mexico Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 40. Brazil Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Latin America Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 42. Middle East & Africa Gene Therapy For Heart Failure Market Share by Country (2016-2027) Figure 43. Turkey Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 44. Saudi Arabia Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 45. UAE Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 46. Rest of Middle East & Africa Gene Therapy For Heart Failure Market Size (2016-2027) & (US$ Million) Figure 47. Bottom-up and Top-down Approaches for This Report Figure 48. Data Triangulation

Askbio RENOVACORINC Uniqure DINAQOR PRECIGEN Heartseed Cardior NOVARTIS Blue Rock